Santa Ana Bio
Alameda, US · Founded 2020 · Delaware corporation · 34 employees on LinkedIn · 5 known investors
Santa Ana Bio develops engineered antibodies targeting immune system pathways to treat autoimmune and inflammatory diseases. The company uses precision therapeutics designed to either suppress overactive immune responses or reactivate dormant ones.
Founders & leadership
Santa Ana Bio was founded in 2020 by Peter Emtage, Alexander Rudensky, Richard Flavell, Graham Lord, and Ansuman Satpathy.
PE
AR
Alexander RudenskyScientific Founder
RF
Richard FlavellScientific Founder
GL
Graham LordScientific Founder
AS
Ansuman SatpathyScientific Founder
Board
TW
JD
Investors · 5
Reported raises · per SEC filings
Form D private placements$63.3M disclosed across 3 rounds · 2021–2024
▶$20MraisedJun 2024 · 10 investors · BiotechnologyRule 506(b)
▶$20MraisedJun 2024 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mittie DoyleDirector
- Peter EmtageExecutive Officer, Director
- Jerel DavisDirector
- Shinichiro FuseDirector
- Brendan Bulik-SullivanDirector
- Christine BorowskiDirector
- Marcelo BigaloDirector
- Offering amount
- $125M
- Amount sold
- $20M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$35.3MraisedFeb 2023 · 5 investors · BiotechnologyRule 506(b)
▶$35.3MraisedFeb 2023 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shinichiro FuseDirector
- Thomas WoiwodeDirector
- Brendan Bulik-SullivanDirector
- Jerel DavisDirector
- Peter EmtageExecutive Officer, Director
- Offering amount
- $70.3M
- Amount sold
- $35.3M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$8MraisedJun 2021 · 1 investors · BiotechnologyRule 506(b)
▶$8MraisedJun 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas WoiwodeDirector
- Peter EmtageExecutive Officer, Director
- Jerel DavisExecutive Officer, Director
- Offering amount
- $42M
- Amount sold
- $8M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Santa Ana Bio went on to found or lead other companies.
In the news
Frequently asked questions
- What does Santa Ana Bio do?
- Santa Ana Bio develops engineered antibodies targeting immune system pathways to treat autoimmune and inflammatory diseases. The company uses precision therapeutics designed to either suppress overactive immune responses or reactivate dormant ones.
- Who founded Santa Ana Bio?
- Santa Ana Bio was founded by Peter Emtage, Alexander Rudensky, Richard Flavell, Graham Lord, Ansuman Satpathy in 2020.
- Who are Santa Ana Bio's investors?
- Santa Ana Bio's investors include Access Biotechnology, Andreessen Horowitz, GV (Google Ventures), Versant Venture Capital, Versant Ventures.
- How much funding has Santa Ana Bio raised?
- Santa Ana Bio has disclosed $63.3M raised across 3 rounds.
- Where is Santa Ana Bio headquartered?
- Santa Ana Bio is headquartered in Alameda, US.